CRTKVA11-03
/ CorreGene
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 18, 2026
Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection
(clinicaltrials.gov)
- P1 | N=6 | Active, not recruiting | Sponsor: Corregene Biotechnology Co., Ltd
New P1 trial • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS
1 to 1
Of
1
Go to page
1